Health reform legislation and an earmarked $1.1 billion have set the stage for the commencement of federally endorsed comparative effectiveness research. But it remains to be seen just how such research will be carried out—and how the results might change health care.
The engine for federally sponsored comparative effectiveness research is the new Patient-Centered Outcomes Research Institute, whose 21-member board of governors, which includes the directors of the Agency for Healthcare Research and Quality and the National Institutes of Health, was announced September 23. The institute, established by the Patient Protection and Affordable Care Act of 2010, is a nonprofit public-private endeavor charged with disbursing funding for comparative effectiveness research.
Mitka M. US Government Kicks Off Program for Comparative Effectiveness Research. JAMA. 2010;304(20):2230-2231. doi:10.1001/jama.2010.1663